MedTrace Logo

The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)

NCT07424313 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2026-02-24

No results posted yet for this study

Summary

This study aims to assess the impact of a low FODMAP diet (LFD) on gastrointestinal symptoms and nutritional status in individuals diagnosed with small intestinal bacterial overgrowth (SIBO). Participants were randomly assigned to either an intervention group or a control group following completion of antibiotic therapy. The intervention group followed a LFD, while the control group followed a normal diet, in accordance with the principles of rational nutrition. Gastrointestinal symptoms, nutritional status, and quality of life were assessed using questionnaires, dietary records, anthropometric measurements, and blood biochemical parameters.

Conditions

  • SIBO
  • Small Intestinal Bacterial Overgrowth
  • Small Intestinal Bacterial Overgrowth Syndrome (SIBO)

Interventions

OTHER

Low FODMAP Diet

Following a low FODMAP diet (elimination and reintroduction phases for 4 and 8 weeks, respectively, for a total of 12 weeks)

OTHER

Healthy Eating Diet

Applying recommendations consistent with proper nutrition principles, with particular focus on breaks between meals and the principle of mindful eating

Sponsors & Collaborators

  • Warsaw University of Life Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-08
Primary Completion
2025-09-18
Completion
2026-01-15

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07424313 on ClinicalTrials.gov